• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国散发性肌萎缩侧索硬化症的早期发病但长期生存和其他预后因素。

Early onset but long survival and other prognostic factors in Chinese sporadic amyotrophic lateral sclerosis.

机构信息

Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

J Clin Neurosci. 2019 Nov;69:74-80. doi: 10.1016/j.jocn.2019.08.030. Epub 2019 Aug 22.

DOI:10.1016/j.jocn.2019.08.030
PMID:31447367
Abstract

OBJECTIVES

To explore the cause of long survival but early onset and other prognostic factors among Chinese sporadic amyotrophic lateral sclerosis (ALS) patients.

METHODS

Patients with ALS were recruited and followed up from Jan 2013 to Jan 2017. Phenotype and survival were compared among different age-at-onset groups. Candidate prognostic factors were analyzed by Kaplan-Meier method, Cox regression and Royston Parmar (RP) model dealing with breaches of proportional hazard assumption.

RESULTS

In the cohort of 531 patients, mean age-at-onset was 53.68 years (SD:10.85) and overall estimated median survival time was 59 months (95% CI: 48.29-69.71). Pairwise comparison showed that patients above 65 years at onset were more frequently bulbar onset (adjusted residual: 3.0), less frequently lumbosacral onset (adjusted residual: -3.0), and had shorter survival compared with other age groups (p = 0.002). Cox and RP model demonstrated independent prognostic variables including age at onset, bulbar onset, diagnostic delay, MRC-score at first diagnosis and region of residence.

CONCLUSIONS

This clinic-based study suggested that Chinese sporadic ALS patients had relatively long survival probably due to young age and less bulbar onset cases. Short diagnostic delay, low MRC-score and northern residence were also predicative of short survival. Reallocation of resources is needed to optimize quality care and prolong survival time.

摘要

目的

探讨中国散发型肌萎缩侧索硬化症(ALS)患者长期生存但发病早的原因及其他预后因素。

方法

2013 年 1 月至 2017 年 1 月,招募并随访了 ALS 患者。比较不同发病年龄组的表型和生存情况。采用 Kaplan-Meier 法、Cox 回归和 Royston Parmar(RP)模型分析候选预后因素,处理违反比例风险假设的情况。

结果

在 531 例患者队列中,发病年龄的平均值为 53.68 岁(标准差:10.85),总估计中位生存时间为 59 个月(95%CI:48.29-69.71)。两两比较显示,发病年龄在 65 岁以上的患者更常为球部起病(校正残差:3.0),更不常为腰骶部起病(校正残差:-3.0),与其他年龄组相比生存时间更短(p=0.002)。Cox 和 RP 模型显示,独立的预后变量包括发病年龄、球部起病、诊断延迟、首次诊断时的 MRC 评分和居住地区。

结论

这项基于临床的研究表明,中国散发型 ALS 患者的生存时间相对较长,可能是因为发病年龄较小,球部起病病例较少。较短的诊断延迟、较低的 MRC 评分和北方居住地区也是生存时间较短的预测因素。需要重新分配资源,以优化护理质量并延长生存时间。

相似文献

1
Early onset but long survival and other prognostic factors in Chinese sporadic amyotrophic lateral sclerosis.中国散发性肌萎缩侧索硬化症的早期发病但长期生存和其他预后因素。
J Clin Neurosci. 2019 Nov;69:74-80. doi: 10.1016/j.jocn.2019.08.030. Epub 2019 Aug 22.
2
Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China.中国散发性肌萎缩侧索硬化的自然史和临床特征。
J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1075-81. doi: 10.1136/jnnp-2015-310471. Epub 2015 Jun 29.
3
The predictors of survival in Chinese amyotrophic lateral sclerosis patients.中国肌萎缩侧索硬化症患者生存的预测因素。
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):237-44. doi: 10.3109/21678421.2014.993650. Epub 2015 Jan 12.
4
Prognostic value of time to generalization in 71 Chinese patients with sporadic amyotrophic lateral sclerosis.71 例散发性肌萎缩侧索硬化症患者广义化时间的预后价值。
Chin Med J (Engl). 2019 May 5;132(9):1023-1027. doi: 10.1097/CM9.0000000000000200.
5
A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis.非高加索裔西班牙裔肌萎缩侧索硬化症患者的临床表型和生存预测因素的回顾性研究。
BMC Neurol. 2019 Oct 29;19(1):261. doi: 10.1186/s12883-019-1459-3.
6
Veterans with familial ALS and bulbar and respiratory presentations at onset had shorter survival.在发病时具有家族性 ALS 和延髓及呼吸表现的退伍军人的生存时间更短。
Sci Prog. 2024 Jul-Sep;107(3):368504241262902. doi: 10.1177/00368504241262902.
7
Clinical Features of Isolated Bulbar Palsy of Amyotrophic Lateral Sclerosis in Chinese Population.中国人群中肌萎缩侧索硬化症孤立性延髓麻痹的临床特征
Chin Med J (Engl). 2017 Aug 5;130(15):1768-1772. doi: 10.4103/0366-6999.211538.
8
Time of symptoms beyond the bulbar region predicts survival in bulbar onset amyotrophic lateral sclerosis.球部起病肌萎缩侧索硬化症中球部外症状出现时间预测生存。
Neurol Sci. 2022 Mar;43(3):1817-1822. doi: 10.1007/s10072-021-05556-w. Epub 2021 Aug 12.
9
Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010.1995 年至 2010 年间诊断的爱尔兰肌萎缩侧索硬化症患者的生存分析。
PLoS One. 2013 Sep 30;8(9):e74733. doi: 10.1371/journal.pone.0074733. eCollection 2013.
10
[Nature history of amyotrophic lateral sclerosis].[肌萎缩侧索硬化症的自然病史]
Zhonghua Yi Xue Za Zhi. 2014 Mar 11;94(9):674-7.

引用本文的文献

1
Lived Experiences of Physiotherapists in Caring for People with Advanced Amyotrophic Lateral Sclerosis in Portugal: A Phenomenological Study.葡萄牙物理治疗师照顾晚期肌萎缩侧索硬化症患者的生活经历:一项现象学研究。
Behav Sci (Basel). 2025 Apr 10;15(4):510. doi: 10.3390/bs15040510.
2
Current State and Future Directions in the Therapy of ALS.肌萎缩侧索硬化症治疗的现状与未来方向。
Cells. 2023 May 31;12(11):1523. doi: 10.3390/cells12111523.
3
Age of Onset and Length of Survival of Queensland Patients with Amyotrophic Lateral Sclerosis: Details of Subjects with Early Onset and Subjects with Long Survival.
昆士兰肌萎缩侧索硬化症患者的发病年龄和存活时间:早发型患者和长期存活患者的详细情况。
Neurodegener Dis. 2022;22(3-4):104-121. doi: 10.1159/000528875. Epub 2022 Dec 30.
4
Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症外周免疫激活的评估
Front Neurol. 2021 Jun 24;12:628710. doi: 10.3389/fneur.2021.628710. eCollection 2021.
5
Mutation Screening of the Gene in a Large Chinese Cohort of Amyotrophic Lateral Sclerosis Patients.在中国一大群肌萎缩侧索硬化症患者中对该基因进行突变筛查。
Front Neurosci. 2021 May 5;15:595775. doi: 10.3389/fnins.2021.595775. eCollection 2021.
6
Clinical Determinants of Disease Progression in Amyotrophic Lateral Sclerosis-A Retrospective Cohort Study.肌萎缩侧索硬化症疾病进展的临床决定因素——一项回顾性队列研究
J Clin Med. 2021 Apr 12;10(8):1623. doi: 10.3390/jcm10081623.